Emma is the Global Account Director for one of our Key, strategic life sciences customers at SAS. She has a passion for life sciences, particularly pharmacogenomics and translational medicine. Emma holds a BSc in Neuroscience and an MSc in Stratified Medicine and Pharmacological Innovation, both from the University of Glasgow. Over the last 7 years, Emma has predominantly worked in the enterprise analytics space, collaborating with large hospitals, universities, research collaborations and university medical centres across the UK and Europe, supporting them with their digital transformation, cyber security, data management and information governance strategies. During her tenure at SAS, Emma has led numerous projects, driving high-value innovation and AI adoption through cloud migration, computer vision, text analytics/NLP and open-source integration on the SAS Viya platform.
For life sciences companies, effective commercial execution depends on delivering useful information to healthcare providers. How can your business manage engagement intelligently across all channels? The pace of pharmaceutical development is accelerating faster than ever before. During the pandemic, life sciences leaders proved that the industry can react to emerging
To achieve this kind of Intelligent Decisioning across hundreds of thousands of customer accounts, you can’t rely on manual analysis.
At SAS, we use the term “Intelligent Decisioning” to describe the type of technology needed to fill this gap. Read more about it.
